跳至主要内容
临床试验/NCT03209726
NCT03209726已完成不适用

Assessment of Subcutaneous Implantable Cardioverter Defibrillator Eligibility With 12-lead Electrocardiogram

Larisa Tereshchenko1 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2017年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
106
试验地点
1
主要终点
Amplitudes of R- and T-waves (and R/T ratios) on a special precordial ECG

研究概览

简要总结

The primary objective of this study is to develop an approach to determine eligibility for subcutaneous ICD by analyzing routine clinical 12-lead electrocardiogram.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • medical condition, predisposing patient to life-threatening ventricular arrhythmias, eligible for currently approved ICD indications for primary or secondary prevention of sudden cardiac death

排除标准

  • Acute medical condition (e.g. acute myocardial infarction, severe trauma, post-surgery, admitted to ICU)
  • End stage organ failure
  • Pregnancy
  • Patient, legal guardian or authorized representative is unable or unwilling to cooperate or give written informed consent

结局指标

主要结局

Amplitudes of R- and T-waves (and R/T ratios) on a special precordial ECG

时间窗: at the day of ECG recording (cross-sectional study)

Amplitudes of R- and T-waves (and R/T ratios) on a special ECG (recorded for Subcutaneous ICD eligibility assessment)

次要结局

未报告次要终点

研究者

发起方
Larisa Tereshchenko
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Larisa Tereshchenko

Associate Professor of Medicine

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验